Kendler Kenneth S, Ohlsson Henrik, Svikis Dace S, Sundquist Kristina, Sundquist Jan
From the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Am J Psychiatry. 2017 Oct 1;174(10):954-962. doi: 10.1176/appi.ajp.2017.16091006. Epub 2017 Jun 9.
The authors sought to determine whether pregnancy is an intrinsic motivator for cessation of drug abuse.
The authors conducted prospective cohort, co-relative, co-spouse, and within-person analyses of registration for drug abuse during pregnancy among Swedish women born between 1980 and 1990 who gave birth between ages 20 and 35 (N=149,512). Drug abuse was assessed from medical, criminal, and pharmacy registries.
In the population, rates of drug abuse were lower during pregnancy (unadjusted odds ratio=0.67, 95% CI=0.60, 0.74). Compared with population results, the negative association between pregnancy and drug abuse was moderately stronger in cousins (odds ratio=0.49, 95% CI=0.39, 0.62) and substantially stronger in siblings (odds ratio=0.35, 95% CI=0.24, 0.51) discordant for pregnancy. The estimated odds ratio for drug abuse in pregnancy-discordant monozygotic twins was even stronger, at 0.17 (95% CI=0.10, 0.31). Within individuals, the odds ratio for drug abuse while pregnant compared with an equivalent prepregnancy interval was similar to that seen in pregnancy-discordant monozygotic twins, at 0.22 (95% CI=0.19, 0.26). Compared with cohabiting fathers, mothers had a greater reduction in risk for drug abuse during pregnancy (odds ratio=0.40, 95% CI=0.34, 0.47). Pregnancy was more protective in women with low parental education and without a cohabiting, actively drug-abusing father. Compared with prepregnancy baseline, within-individual analyses indicate that risk for drug abuse is also substantially reduced in the postpartum period, for example, the odds ratio for postpartum days 0-242 was 0.13 (95% CI=0.11, 0.16).
Risk for drug abuse in women is substantially reduced during pregnancy. Multiple analyses suggest that this association is largely causal, suggesting that pregnancy is indeed a strong intrinsic motivator for drug abuse cessation. Similar strong protective effects may be present in the immediate postpartum period. Our results have implications for our etiologic models of drug abuse and especially for contingency management programs seeking to reduce drug abuse risk.
作者试图确定怀孕是否是戒毒的内在动力。
作者对1980年至1990年间出生、20至35岁分娩的瑞典女性(N = 149,512)孕期药物滥用登记情况进行了前瞻性队列、相关性、配偶及个体内分析。药物滥用情况通过医疗、刑事和药房登记记录进行评估。
在总体人群中,孕期药物滥用率较低(未调整比值比 = 0.67,95%置信区间 = 0.60,0.74)。与总体结果相比,怀孕与药物滥用之间的负相关在堂兄弟姐妹中稍强(比值比 = 0.49,95%置信区间 = 0.39,0.62),在怀孕情况不一致的兄弟姐妹中更强(比值比 = 0.35,95%置信区间 = 0.24,0.51)。怀孕情况不一致的同卵双胞胎药物滥用的估计比值比更强,为0.17(95%置信区间 = 0.10,0.31)。在个体内部,孕期药物滥用的比值比与怀孕情况不一致的同卵双胞胎相似,为0.22(95%置信区间 = 0.19,0.26),与怀孕前相同时间段相比。与同居父亲相比,母亲孕期药物滥用风险降低幅度更大(比值比 = 0.40,95%置信区间 = 0.34,0.47)。怀孕对父母教育程度低且没有同居、积极滥用药物的父亲的女性保护作用更强。与怀孕前基线相比,个体内分析表明产后药物滥用风险也大幅降低,例如,产后0至242天的比值比为0.13(95%置信区间 = 0.11,0.16)。
女性孕期药物滥用风险大幅降低。多项分析表明这种关联在很大程度上是因果关系,表明怀孕确实是戒毒的强大内在动力。产后即刻可能也存在类似的强大保护作用。我们的结果对药物滥用的病因模型有影响,尤其对旨在降低药物滥用风险的应急管理项目有影响。